Sign in

2186 on Hong Kong Stock Exchange

Luye Pharma Group Limited

Its shares trade on Hong Kong Stock Exchange under the symbol 2186.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

Timeline

  1. Jul 9, 2014Went public Listed on Hong Kong Stock Exchange1

Calendar

Drug trials and FDA: coming up

  1. Feb 28, 2027Phase 4 trial readout expected Phase 4 trial of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Major Depressive Disorder: primary completion expected Feb 28, 2027 (ClinicalTrials.gov NCT06426485).2

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2